Renaissance Technologies LLC reduced its holdings in shares of Retractable Technologies, Inc. (NYSE:RVP – Free Report) by 5.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 340,759 shares of the company’s stock after selling 18,134 shares during the quarter. Renaissance Technologies LLC owned approximately 1.14% of Retractable Technologies worth $368,000 as of its most recent filing with the Securities and Exchange Commission.
Retractable Technologies Price Performance
Retractable Technologies stock opened at $0.76 on Friday. Retractable Technologies, Inc. has a 12-month low of $0.71 and a 12-month high of $1.34. The stock has a market capitalization of $22.72 million, a P/E ratio of -1.24 and a beta of 2.06. The firm’s 50-day moving average is $0.90 and its two-hundred day moving average is $1.03. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54.
Retractable Technologies (NYSE:RVP – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The firm had revenue of $6.03 million for the quarter.
Insiders Place Their Bets
Analysts Set New Price Targets
Separately, StockNews.com assumed coverage on shares of Retractable Technologies in a report on Thursday. They set a “hold” rating for the company.
View Our Latest Stock Analysis on RVP
Retractable Technologies Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Read More
- Five stocks we like better than Retractable Technologies
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- Short Selling: How to Short a Stock
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Which Wall Street Analysts are the Most Accurate?
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.